Skip to main content

Advertisement

Log in

Primary Cutaneous Aspergillosis in a Patient with CARD9 Deficiency and Aspergillus Susceptibility of Card9 Knockout Mice

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Purpose

We describe a case of primary cutaneous aspergillosis caused by Aspergillus fumigatus, and elucidate the underlying genetic and immunological mechanisms.

Materials and Methods

Routine clinical and laboratory investigations were performed. Whole-exome sequencing of the patient’s DNA suggested the presence of a CARD9 mutation, which was confirmed by Sanger sequencing. Innate and adaptive immunological responses of patient-derived CARD9-deficient cells were evaluated with ELISA and flow cytometry. Cutaneous and pulmonary aspergillosis models were established in Card9 knockout (KO) mice, which were compared with wild-type and immunosuppressed mice, to explore the pathogenesis and Aspergillus susceptibility.

Results

A 45-year-old man presented with a 37-year history of skin lesions on his face. A diagnosis of primary cutaneous aspergillosis was made through histopathology, immunohistochemistry, and tissue culture. Sanger sequencing of CARD9 showed a homozygous frame-shift mutation (c.819_820insG, p.D274fsX60), which led to the lack of CARD9 expression. Peripheral blood mononuclear cells from the patient showed selective impairment of proinflammatory cytokines, and Th1-, Th17-, and Th22-associated responses upon fungus-specific stimulation. The cutaneous aspergillosis model established in Card9 KO mice presented with persistent infection, with fungal germs and short hyphae in tissue, consistent with the patient’s lesions. Skin lesions in immunosuppressed mice were more severe, and led to death. Unlike our patient, Card9 KO mice were relatively susceptible to pulmonary aspergillosis, with reasons to be investigated.

Conclusions

This is, to our knowledge, the first report that links cutaneous aspergillosis to CARD9 mutation. This work enriches both the phenotypic spectrum of CARD9 deficiencies and the genetic background of cutaneous aspergillosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Tatara AM, Mikos AG, Kontoyiannis DP. Factors affecting patient outcome in primary cutaneous aspergillosis. Medicine (Baltimore). 2016;95(26):e3747.

    Article  Google Scholar 

  2. Darr-Foit S, Schliemann S, Scholl S, Hipler UC, Elsner P. Primary cutaneous aspergillosis - an uncommon opportunistic infection review of the literature and case presentation. J Dtsch Dermatol Ges. 2017;15(8):839–41.

    PubMed  Google Scholar 

  3. Liu X, Yang J, Ma W. Primary cutaneous aspergillosis caused by Aspergillus fumigatus in an immunocompetent patient. Medicine (Baltimore). 2017;96(48):e8916.

    Article  Google Scholar 

  4. Zhong X, Chen B, Yang L, Yang Z. Molecular and physiological roles of the adaptor protein CARD9 in immunity. Cell Death Dis. 2018;9(2):52.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Corvilain E, Casanova J-L, Puel A. Inherited CARD9 deficiency: invasive disease caused by ascomycete fungi in previously healthy children and adults. J Clin Immunol. 2018;38(6):656–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Huang C, Zhang Y, Song Y, Wan Z, Wang X, Li R. Phaeohyphomycosis caused by Phialophora americana with CARD9 mutation and 20-year literature review in China. Mycoses. 2019;62(10):908–19.

    Article  CAS  PubMed  Google Scholar 

  7. Wu W, Zhang R, Wang X, Song Y, Liu Z, Han W, et al. Impairment of immune response against dematiaceous fungi in Card9 knockout mice. Mycopathologia. 2016;181(9–10):631–42.

    Article  CAS  PubMed  Google Scholar 

  8. van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latgé JP. Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol. 2017;15(11):661–74.

    Article  PubMed  CAS  Google Scholar 

  9. Kartik M, Kanala A, Sunilnadikuda, Rao SM, Prakasham PS. Invasive mediastinal Aspergillosis in immunocompetent male with invasion of left atrium and hilar structures. Indian J Crit Care Med. 2017;21(6):408–11.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Latgé JP, Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clin Microbiol Rev. 2019;33(1):e00140–18.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Venugopal TV, Venugopal PV. Primary cutaneous aspergillosis from Tamilnadu diagnosed by fine needle aspiration cytology. Med Mycol Case Rep. 2012;1(1):103–6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bernardeschi C, Foulet F, Ingen-Housz-Oro S, Ortonne N, Sitbon K, Quereux G, et al. Cutaneous invasive aspergillosis: retrospective multicenter study of the French invasive-aspergillosis registry and literature review. Medicine (Baltimore). 2015;94(26):e1018.

    Article  Google Scholar 

  13. Fernandez-Flores A, Saeb-Lima M, Arenas-Guzman R. Morphological findings of deep cutaneous fungal infections. Am J Dermatopathol. 2014;36(7):531–53 quiz 554–6.

    Article  PubMed  Google Scholar 

  14. Shields BE, Rosenbach M, Brown-Joel Z, Berger AP, Ford BA, Wanat KA. Angioinvasive fungal infections impacting the skin: background, epidemiology, and clinical presentation. J Am Acad Dermatol. 2019;80(4):869–80.e5.

    Article  PubMed  Google Scholar 

  15. Gallais F, Denis J, Koobar O, Dillenseger L, Astruc D, Herbrecht R, et al. Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature. BMC Infect Dis. 2017;17(1):535.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Challa S, Uppin SG, Uppin MS, Pamidimukkala U, Vemu L. Diagnosis of filamentous fungi on tissue sections by immunohistochemistry using anti-aspergillus antibody. Med Mycol. 2015;53(5):470–6.

    Article  CAS  PubMed  Google Scholar 

  17. Jung J, Park YS, Sung H, Song JS, Lee S-O, Choi S-H, et al. Using of immunohistochemistry to assess the accuracy of histomorphologic diagnosis of aspergillosis and mucormycosis. Clin Infect Dis. 2015;61(11):1664–70.

    CAS  PubMed  Google Scholar 

  18. Glocker EO, Hennigs A, Nabavi M, Schäffer AA, Woellner C, Salzer U, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009;361(18):1727–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Vaezi A, Fakhim H, Abtahian Z, Khodavaisy S, Geramishoar M, Alizadeh A, et al. Frequency and geographic distribution of CARD9 mutations in patients with severe fungal infections. Front Microbiol. 2018;9:2434.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Drewniak A, Gazendam RP, Tool AT, van Houdt M, Jansen MH, van Hamme JL, et al. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood. 2013;121(13):2385–92.

    Article  CAS  PubMed  Google Scholar 

  21. Gavino C, Cotter A, Lichtenstein D, Lejtenyi D, Fortin C, Legault C, et al. CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy. Clin Infect Dis. 2014;59(1):81–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Drummond RA, Collar AL, Swamydas M, Rodriguez CA, Lim JK, Mendez LM, et al. CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system. PLoS Pathog. 2015;11(12):e1005293.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Herbst M, Gazendam R, Reimnitz D, Sawalle-Belohradsky J, Groll A, Schlegel PG, et al. Chronic Candida albicans meningitis in a 4-year-old girl with a homozygous mutation in the CARD9 gene (Q295X). Pediatr Infect Dis J. 2015;34(9):999–1002.

    Article  PubMed  Google Scholar 

  24. Lanternier F, Mahdaviani SA, Barbati E, Chaussade H, Koumar Y, Levy R, et al. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. J Allergy Clin Immunol. 2015;135(6):1558–68.e2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Alves de Medeiros AK, Lodewick E, Bogaert DJ, Haerynck F, Van Daele S, Lambrecht B, et al. Chronic and invasive fungal infections in a family with CARD9 deficiency. J Clin Immunol. 2016;36(3):204–9.

    Article  PubMed  Google Scholar 

  26. Celmeli F, Oztoprak N, Turkkahraman D, Seyman D, Mutlu E, Frede N, et al. Successful granulocyte colony-stimulating factor treatment of relapsing Candida albicans meningoencephalitis caused by CARD9 deficiency. Pediatr Infect Dis J. 2016;35(4):428–31.

    Article  PubMed  Google Scholar 

  27. Gavino C, Hamel N, Zeng JB, Legault C, Guiot MC, Chankowsky J, et al. Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians. J Allergy Clin Immunol. 2016;137(4):1178–88.e7.

    Article  CAS  PubMed  Google Scholar 

  28. Jones N, Garcez T, Newman W, Denning D. Endogenous Candida endophthalmitis and osteomyelitis associated with CARD9 deficiency. BMJ Case Rep. 2016;2016:bcr2015214117.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lanternier F, Pathan S, Vincent QB, Liu L, Cypowyj S, Prando C, et al. Deep dermatophytosis and inherited CARD9 deficiency. N Engl J Med. 2013;369(18):1704–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Grumach AS, de Queiroz-Telles F, Migaud M, Lanternier F, Filho NR, Palma SM, et al. A homozygous CARD9 mutation in a Brazilian patient with deep dermatophytosis. J Clin Immunol. 2015;35(5):486–90.

    Article  CAS  PubMed  Google Scholar 

  31. Jachiet M, Lanternier F, Rybojad M, Bagot M, Ibrahim L, Casanova JL, et al. Posaconazole treatment of extensive skin and nail dermatophytosis due to autosomal recessive deficiency of CARD9. JAMA Dermatol. 2015;151(2):192–4.

    Article  PubMed  Google Scholar 

  32. Boudghene Stambouli O, Amrani N, Boudghene Stambouli K, Bouali F. Dermatophytic disease with deficit in CARD9: a new case with a brain impairment. J Mycol Med. 2017;27(2):250–3.

    Article  CAS  PubMed  Google Scholar 

  33. Zhang Y, Mijiti J, Huang C, Song Y, Wan Z, Li R, et al. Deep dermatophytosis caused by Microsporum ferrugineum in a patient with CARD9 mutations. Br J Dermatol. 2019;181(5):1093–5.

    Article  CAS  PubMed  Google Scholar 

  34. Nazarian RM, Lilly E, Gavino C, Hamilos DL, Felsenstein D, Vinh DC, et al. Novel CARD9 mutation in a patient with chronic invasive dermatophyte infection (tinea profunda). J Cutan Pathol. 2020;47(2):166–70.

    Article  PubMed  Google Scholar 

  35. Huang C, Peng Y, Zhang Y, Li R, Wan Z, Wang X. Deep dermatophytosis caused by Trichophyton rubrum. Lancet Infect Dis. 2019;19(12):1380.

    Article  PubMed  Google Scholar 

  36. Wang X, Wang W, Lin Z, Wang X, Li T, Yu J, et al. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. J Allergy Clin Immunol. 2014;133(3):905–8.e3.

    Article  CAS  PubMed  Google Scholar 

  37. Lanternier F, Barbati E, Meinzer U, Liu L, Pedergnana V, Migaud M, et al. Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection. J Infect Dis. 2015;211(8):1241–50.

    Article  CAS  PubMed  Google Scholar 

  38. Wang X, Zhang R, Wu W, Song Y, Wan Z, Han W, et al. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J Invest Dermatol. 2018;138(3):607–17.

    Article  CAS  PubMed  Google Scholar 

  39. Arango-Franco CA, Moncada-Velez M, Beltran CP, Berrio I, Mogollon C, Restrepo A, et al. Early-onset invasive infection due to Corynespora cassiicola associated with compound heterozygous CARD9 mutations in a Colombian patient. J Clin Immunol. 2018;38(7):794–803.

    Article  CAS  PubMed  Google Scholar 

  40. Guo Y, Zhu Z, Gao J, Zhang C, Zhang X, Dang E, et al. The phytopathogenic fungus Pallidocercospora crystallina-caused localized subcutaneous phaeohyphomycosis in a patient with a homozygous missense CARD9 mutation. J Clin Immunol. 2019;39(7):713–25.

    Article  CAS  PubMed  Google Scholar 

  41. Wang C, Xing H, Jiang X, Zeng J, Liu Z, Chen J, et al. Cerebral phaeohyphomycosis caused by Exophiala dermatitidis in a Chinese CARD9-deficient patient: a case report and literature review. Front Neurol. 2019;10:938.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Perez L, Messina F, Negroni R, Arechavala A, Bustamante J, Oleastro M, et al. Inherited CARD9 deficiency in a patient with both Exophiala spinifera and Aspergillus nomius severe infections. J Clin Immunol. 2020;40(2):359–66.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Rieber N, Gazendam RP, Freeman AF, Hsu AP, Collar AL, Sugui JA, et al. Extrapulmonary Aspergillus infection in patients with CARD9 deficiency. JCI Insight. 2016;1(17):e89890.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Wang X, Wang A, Wang X, Li R, Yu J. Cutaneous mucormycosis caused by Mucor irregularis in a patient with CARD9 deficiency. Br J Dermatol. 2019;180(1):213–4.

    Article  CAS  PubMed  Google Scholar 

  45. Quan C, Li X, Shi RF, Zhao XQ, Xu H, Wang B, et al. Recurrent fungal infections in a Chinese patient with CARD9 deficiency and a review of 48 cases. Br J Dermatol. 2018;180(5):1221–5.

    Article  PubMed  CAS  Google Scholar 

  46. Erman B, Firtina S, Aksoy BA, Aydogdu S, Genc GE, Dogan O, et al. Invasive Saprochaete capitata infection in a patient with autosomal recessive CARD9 deficiency and a review of the literature. J Clin Immunol. 2020;40(3):466–74.

    Article  CAS  PubMed  Google Scholar 

  47. Lionakis MS, Iliev ID, Hohl TM. Immunity against fungi. JCI Insight. 2017;2(11):e93156.

    Article  PubMed Central  Google Scholar 

  48. Gessner MA, Werner JL, Lilly LM, Nelson MP, Metz AE, Dunaway CW, et al. Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. Infect Immun. 2012;80(1):410–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Rubino I, Coste A, Le Roy D, Roger T, Jaton K, Boeckh M, et al. Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6. J Infect Dis. 2012;205(6):944–54.

    Article  CAS  PubMed  Google Scholar 

  50. Wu W, Zhang R, Wang X, Song Y, Li R. Subcutaneous infection with dematiaceous fungi in Card9 knockout mice reveals association of impair neutrophils and Th cell response. J Dermatol Sci. 2018;92(2):215–8.

    Article  CAS  PubMed  Google Scholar 

  51. Grahl N, Shepardson KM, Chung D, Cramer RA. Hypoxia and fungal pathogenesis: to air or not to air? Eukaryot Cell. 2012;11(5):560–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Drummond RA, Swamydas M, Oikonomou V, Zhai B, Dambuza IM, Schaefer BC, et al. CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment. Nat Immunol. 2019;20(5):559–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank the patient, his family members, and healthy donors for their participation in this study. We also thank Huihui Liu for technical advice on the analysis of FACS results and Jin Shao for help with the immunohistochemistry of patient’s tissue sections.

Funding

This work was supported by the International Cooperation and Exchanges Project from National Natural Science Foundation of China (NSFC No. 81520108026) and the National Natural Science Foundation of China (NSFC No. 81872539).

Author information

Authors and Affiliations

Authors

Contributions

X.W. and R.L. are the principal investigators who conceived this study. Y.Z. and C.H. conducted the research, and analyzed and interpreted the data. Z.W. and Y.S. contributed with the identification of the fungus. Y.M. participated in animal experiments. X.Z. provided the clinical oversight of the patient. Y.Z. drafted the manuscript and X.W. and R.L. critically revised the manuscript.

Corresponding authors

Correspondence to Xiaowen Wang or Ruoyu Li.

Ethics declarations

This study was approved by the Clinical Research Ethics Committee of the Peking University First Hospital. We obtained blood samples from the patient, his son, and three ethnically matched healthy volunteers, after obtaining informed consent. The patient gave permission to publish his images and medical information. Animal studies were approved by the Institutional Ethics Committee of Peking University First Hospital in accordance with the institutional guidelines.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(PDF 770 kb).

ESM 2

(PDF 288 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Huang, C., Song, Y. et al. Primary Cutaneous Aspergillosis in a Patient with CARD9 Deficiency and Aspergillus Susceptibility of Card9 Knockout Mice. J Clin Immunol 41, 427–440 (2021). https://doi.org/10.1007/s10875-020-00909-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00909-0

Keywords

Navigation